Adcy5em1(R419W)

Status

Available to order

EMMA IDEM:16082
Citation informationRRID:IMSR_EM:16082 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameAdcy5em1(R419W)
Alternative nameAdcy5em1(R419W)
Strain typeEndonuclease-mediated
Allele/Transgene symbolAdcy5
Gene/Transgene symbolAdcy5

Information from provider

ProviderEmmanuel Roze
Provider affiliationservice de neurologie / troubles du mouvement, AP‑HP Sorbonne Université
Genetic informationThe Adcy5supR419W/sup mouse line was generated on a C57BL/6N background using CRISPR/Cas9-mediated genome editing at the Institut Clinique de la Souris – PHENOMIN (http://www.phenomin.fr). Mutations were introduced into exon 2 of the Adcy5 gene (ENSMUSG00000022840), located on chromosome 16. Four mutations were simultaneously introduced into wild-type C57BL/6N embryos (Extended Data Fig. 5a). A CRISPR ribonucleoprotein complex—comprising a crRNA (5′-GCCGAGCCTGGATACACTCC-3′; MIT score: 88, as predicted by the CRISPOR website), tracrRNA, and wild-type Cas9—was co-electroporated with a 128-nucleotide single-stranded donor DNA into fertilized C57BL/6N oocytes. Resulting founders were selected based on genotyping and confirmed by Sanger sequencing. Among these, the c.1255C
Phenotypic informationHomozygous:
Heterozygous Adcy5 mutant mice from the selected founder line were backcrossed to the C57BL/6N background for at least 10 generations. Genotype distribution among Adcy5 littermates followed Mendelian ratios, and no lethality was observed in homozygous or heterozygous mutants during embryogenesis, at birth, or in the pre-weaning period.

Heterozygous:
see doi: 10.2139/ssrn.5399781
Breeding historyThe founder was bred with C57BL/6N wild type mouse. All backcrosses were performed on C57BL/6N genetic background and the sperm from F3 heterozygous animals was cryopreserved
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).